Cargando…
The carboxyl-terminal sequence of PUMA binds to both anti-apoptotic proteins and membranes
Anti-apoptotic proteins such as BCL-X(L) promote cell survival by sequestering pro-apoptotic BCL-2 family members, an activity that frequently contributes to tumorigenesis. Thus, the development of small-molecule inhibitors for anti-apoptotic proteins, termed BH3-mimetics, is revolutionizing how we...
Autores principales: | Pemberton, James M, Nguyen, Dang, Osterlund, Elizabeth J, Schormann, Wiebke, Pogmore, Justin P, Hirmiz, Nehad, Leber, Brian, Andrews, David W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185343/ https://www.ncbi.nlm.nih.gov/pubmed/37078707 http://dx.doi.org/10.7554/eLife.88329 |
Ejemplares similares
-
Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1
por: Jenson, Justin M, et al.
Publicado: (2017) -
Endoplasmic reticulum protein BIK binds to and inhibits mitochondria-localized antiapoptotic proteins
por: Osterlund, Elizabeth J., et al.
Publicado: (2023) -
The carboxyl-terminal sequence of bim enables bax activation and killing of unprimed cells
por: Chi, Xiaoke, et al.
Publicado: (2020) -
Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells
por: Osterlund, Elizabeth J., et al.
Publicado: (2022) -
Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2
por: Liu, Qian, et al.
Publicado: (2019)